Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ploeger

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
British Journal of Clinical Pharmacology|July 30, 2021
Assessment of the safe and efficacious dose of the selective progesterone receptor modulator vilaprisan for the treatment of patients with uterine fibroids by exposure-response modelling and simulationGabriele Sutter, Matthias Frei, Marcus-Hillert Schultze-Mosgau, et al.
Anesthesiology|December 24, 2008
Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadexBart A Ploeger, Jean Smeets, Ashley Strougo, et al.
Trends in Pharmacological Sciences|March 21, 2008
Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug researchMeindert Danhof, Elizabeth C M de Lange, Oscar E Della Pasqua, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 10, 2011
Systemic and direct nose-to-brain transport pharmacokinetic model for remoxipride after intravenous and intranasal administrationJasper Stevens, Bart A Ploeger, Piet H van der Graaf, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 13, 2011
A hidden Markov model to assess drug-induced sleep fragmentation in the telemetered ratC Diack, O Ackaert, B A Ploeger, et al.
European Journal of Endocrinology|January 12, 2011
Mitotane has a strong and a durable inducing effect on CYP3A4 activityNielka P van Erp, Henk-Jan Guchelaar, Bart A Ploeger, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2007
Kidney transplantation in patients with antibodies against donor HLA class IIH S Pollinger, M D Stegall, J M Gloor, et al.
Immunobiology|November 19, 2011
Human macrophages primed with angiogenic factors show dynamic plasticity, irrespective of extracellular matrix componentsDiana T A Ploeger, Sander M van Putten, Jasper A Koerts, et al.
Annual Review of Pharmacology and Toxicology|October 28, 2006
Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysisMeindert Danhof, Joost de Jongh, Elizabeth C M De Lange, et al.
British Journal of Pharmacology|June 26, 2014
Drug effects on the CVS in conscious rats: separating cardiac output into heart rate and stroke volume using PKPD modellingN Snelder, B A Ploeger, O Luttringer, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
British Journal of Clinical Pharmacology|July 30, 2021
Assessment of the safe and efficacious dose of the selective progesterone receptor modulator vilaprisan for the treatment of patients with uterine fibroids by exposure-response modelling and simulationGabriele Sutter, Matthias Frei, Marcus-Hillert Schultze-Mosgau, et al.
Anesthesiology|December 24, 2008
Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadexBart A Ploeger, Jean Smeets, Ashley Strougo, et al.
Trends in Pharmacological Sciences|March 21, 2008
Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug researchMeindert Danhof, Elizabeth C M de Lange, Oscar E Della Pasqua, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 10, 2011
Systemic and direct nose-to-brain transport pharmacokinetic model for remoxipride after intravenous and intranasal administrationJasper Stevens, Bart A Ploeger, Piet H van der Graaf, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 13, 2011
A hidden Markov model to assess drug-induced sleep fragmentation in the telemetered ratC Diack, O Ackaert, B A Ploeger, et al.
European Journal of Endocrinology|January 12, 2011
Mitotane has a strong and a durable inducing effect on CYP3A4 activityNielka P van Erp, Henk-Jan Guchelaar, Bart A Ploeger, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2007
Kidney transplantation in patients with antibodies against donor HLA class IIH S Pollinger, M D Stegall, J M Gloor, et al.
Immunobiology|November 19, 2011
Human macrophages primed with angiogenic factors show dynamic plasticity, irrespective of extracellular matrix componentsDiana T A Ploeger, Sander M van Putten, Jasper A Koerts, et al.
Annual Review of Pharmacology and Toxicology|October 28, 2006
Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysisMeindert Danhof, Joost de Jongh, Elizabeth C M De Lange, et al.
British Journal of Pharmacology|June 26, 2014
Drug effects on the CVS in conscious rats: separating cardiac output into heart rate and stroke volume using PKPD modellingN Snelder, B A Ploeger, O Luttringer, et al.
Pageof 7